Sarcoma  >>  emactuzumab (RG7155)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
emactuzumab (RG7155) / SynOx Therap
NCT02323191: A Study of Emactuzumab and Atezolizumab Administered in Combination in Participants With Advanced Solid Tumors

Hourglass Jan 2018 - Dec 2018 : Data (advanced)
Completed
1
221
Europe, US
Atezolizumab, MPDL3280A, TECENTRIQ, Emactuzumab, RO5509554
Hoffmann-La Roche
Solid Cancers
08/20
08/20

Download Options